WEKO3
アイテム
{"_buckets": {"deposit": "f6146a42-ce06-414f-9c4d-86131844bbb0"}, "_deposit": {"created_by": 1, "id": "63849", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "63849"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00063849", "sets": ["29"]}, "author_link": ["629874", "629867", "629871", "629876", "629879", "629877", "629868", "629873", "629878", "629880", "629872", "629875", "629870", "629869"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2010-03-21", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The Heavy Ion Medical Accelerator in Chiba (HIMAC) is the world\u0027s first heavy ion accelerator complex dedicated to medical use in a hospital environment. Heavy ions have superior depth-dose distribution and greater cell-killing capability. In June 1996, clinical research for the treatment of bone and soft tissue sarcomas was begun using carbon ions generated by the HIMAC. As of August 2009, a total of 471 patients with bone and soft tissue sarcoma were enrolled into the clinical trials. Most of the patients had locally advanced and/or medically inoperable sarcomas. The clinical trial revealed that carbon ion radiotherapy provided definite local control and offered a survival advantage without unacceptable morbidity in bone and soft tissue sarcomas that were hard to cure with other modalities.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "II NIRS-CNAO Joint Symposium on Hadrontherapy", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kamada, Tadashi"}], "nameIdentifiers": [{"nameIdentifier": "629867", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Imai, Reiko"}], "nameIdentifiers": [{"nameIdentifier": "629868", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsuji, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "629869", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Suzuki, Motohisa"}], "nameIdentifiers": [{"nameIdentifier": "629870", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okada, Tohru"}], "nameIdentifiers": [{"nameIdentifier": "629871", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sugahara, Shinji"}], "nameIdentifiers": [{"nameIdentifier": "629872", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsujii, Hirohiko"}], "nameIdentifiers": [{"nameIdentifier": "629873", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鎌田 正", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "629874", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "今井 礼子", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "629875", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻 比呂志", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "629876", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "鈴木 志恒", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "629877", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "岡田 徹", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "629878", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "菅原 信二", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "629879", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻井 博彦", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "629880", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas"}]}, "item_type_id": "10005", "owner": "1", "path": ["29"], "permalink_uri": "https://repo.qst.go.jp/records/63849", "pubdate": {"attribute_name": "公開日", "attribute_value": "2010-03-24"}, "publish_date": "2010-03-24", "publish_status": "0", "recid": "63849", "relation": {}, "relation_version_is_last": true, "title": ["Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas"], "weko_shared_id": -1}
Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas
https://repo.qst.go.jp/records/63849
https://repo.qst.go.jp/records/638495db21b48-e536-4ea9-a3e9-60079984c40a
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2010-03-24 | |||||
タイトル | ||||||
タイトル | Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Kamada, Tadashi
× Kamada, Tadashi× Imai, Reiko× Tsuji, Hiroshi× Suzuki, Motohisa× Okada, Tohru× Sugahara, Shinji× Tsujii, Hirohiko× 鎌田 正× 今井 礼子× 辻 比呂志× 鈴木 志恒× 岡田 徹× 菅原 信二× 辻井 博彦 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The Heavy Ion Medical Accelerator in Chiba (HIMAC) is the world's first heavy ion accelerator complex dedicated to medical use in a hospital environment. Heavy ions have superior depth-dose distribution and greater cell-killing capability. In June 1996, clinical research for the treatment of bone and soft tissue sarcomas was begun using carbon ions generated by the HIMAC. As of August 2009, a total of 471 patients with bone and soft tissue sarcoma were enrolled into the clinical trials. Most of the patients had locally advanced and/or medically inoperable sarcomas. The clinical trial revealed that carbon ion radiotherapy provided definite local control and offered a survival advantage without unacceptable morbidity in bone and soft tissue sarcomas that were hard to cure with other modalities. | |||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | II NIRS-CNAO Joint Symposium on Hadrontherapy | |||||
発表年月日 | ||||||
日付 | 2010-03-21 | |||||
日付タイプ | Issued |